newsfilter
← Latest News
GlobeNewswire·

Larimar Therapeutics Announces Proposed Underwritten Public Offering

BALA CYNWYD, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. ("Larimar") (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today